Drug shortages homepage

Welcome to Drug Shortages Canada, the website for mandatory reporting of drug shortages and discontinuations by market authorization holders. Anyone can search the database of shortage and discontinuation reports. More information can be found on the About & Resources Page.

Early reporting of shortages and discontinuations provides Health Canada, provincial/territorial governments, drug supply chain stakeholders, and health professionals details needed to help them monitor and manage supply. Shortages can be caused by many factors. Some last longer and are more complex than others. Because companies have to report every time they cannot fully meet demand, not all of the reports on this site are cause for concern at the patient level. Most are successfully managed before they impact patients.

The shortage database has a flag that indicates ones that are Tier 3 drug shortages, which are those that could potentially have the highest impact on Canada's drug supply and health care system. A Tier 3 designation is decided by the Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders.

Ensuring people can get the medicines they need is a top priority for Health Canada. Health Canada works closely with many partners to prevent shortages, mitigate their impacts, and help resolve them when they occur.

If you would like to know more about shortages like why they happen, how long they last, the actions being taken to reduce impacts on Canadians, and actions you can take if a drug you use is in shortage, please consult the information on Canada.ca.

Below are the newest shortage and discontinuation reports and updates to existing ones.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
SURVANTA ABBVIE CORPORATION Resolved 25MG Updated Report 2024-05-11 226027
VISIPAQUE 270 GE HEALTHCARE CANADA INC Actual shortage 550MG Updated Report 2024-05-11 227151
MIDAZOLAM INJECTION SANDOZ CANADA INCORPORATED Resolved 5MG Updated Report 2024-05-11 192022
AVENTYL AA PHARMA INC Resolved 10MG Updated Report 2024-05-11 224511
BREVICON 0.5/35 TABLETS (28-DAY PACK) PFIZER CANADA ULC Actual shortage .5MG .035MG Updated Report 2024-05-11 226997
ARTHROTEC 75 PFIZER CANADA ULC Actual shortage 200MCG 75MG Updated Report 2024-05-11 227000
ACH-OLMESARTAN HCTZ ACCORD HEALTHCARE INC Actual shortage 40MG 25MG Updated Report 2024-05-11 227794
APO-FINGOLIMOD APOTEX INC Actual shortage 0.5MG Updated Report 2024-05-10 216744
APO-TICAGRELOR APOTEX INC Actual shortage 90MG Updated Report 2024-05-10 225026
APO-WARFARIN APOTEX INC Actual shortage 1MG Updated Report 2024-05-10 225782
APO-WARFARIN APOTEX INC Actual shortage 1MG Updated Report 2024-05-10 224589
APO-ATORVASTATIN APOTEX INC Actual shortage 80MG Updated Report 2024-05-10 227088
METHOTREXATE SUBCUTANEOUS ACCORD HEALTHCARE INC Resolved 20MG Updated Report 2024-05-10 225687
ACH-SOLIFENACIN SUCCINATE ACCORD HEALTHCARE INC Actual shortage 5MG New Report 2024-05-10 227797
COTAZYM ORGANON CANADA INC. Anticipated shortage 35000UNIT 40000UNIT 10000UNIT Updated Report 2024-05-10 225096
PMS-TENOFOVIR PHARMASCIENCE INC Actual shortage 300MG New Report 2024-05-10 227785
APO-TRIMEBUTINE APOTEX INC Resolved 100MG Updated Report 2024-05-10 225767
APO-OXCARBAZEPINE APOTEX INC Resolved 300MG Updated Report 2024-05-10 224598
APO-OXCARBAZEPINE APOTEX INC Resolved 150MG Updated Report 2024-05-10 219159
PMS-METRONIDAZOLE PHARMASCIENCE INC Actual shortage 500MG New Report 2024-05-10 227776

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
MYLAN-NITRO SUBLINGUAL SPRAY MYLAN PHARMACEUTICALS ULC Discontinued 0.4MG New Report 2024-05-08 227338
CHAMPIX PFIZER CANADA ULC Discontinued 1MG 0.5MG New Report 2024-05-03 227052
CHAMPIX PFIZER CANADA ULC Discontinued 1MG New Report 2024-05-03 227049
CHAMPIX PFIZER CANADA ULC Discontinued 0.5MG New Report 2024-05-03 227046
AUBAGIO SANOFI-AVENTIS CANADA INC To be discontinued 14MG New Report 2024-05-02 226847
SANDOZ OXYCODONE/ACETAMINOPHEN SANDOZ CANADA INCORPORATED Discontinued 325MG 5MG Updated Report 2024-05-02 226748
SANDOZ OXYCODONE/ACETAMINOPHEN SANDOZ CANADA INCORPORATED Discontinued 325MG 5MG Updated Report 2024-05-02 226753
HUMULIN R ELI LILLY CANADA INC To be discontinued 100UNIT New Report 2024-05-02 224344
SANDOZ D 10 000 SANDOZ CANADA INCORPORATED Discontinued 10000UNIT Updated Report 2024-05-02 226738
SANDOZ DOCUSATE SODIUM SANDOZ CANADA INCORPORATED Discontinued 100MG Updated Report 2024-05-02 226758
PANECTYL SEARCHLIGHT PHARMA INC To be discontinued 2.5MG New Report 2024-04-30 226633
ISENTRESS MERCK CANADA INC To be discontinued 25MG Updated Report 2024-04-29 204164
ISENTRESS MERCK CANADA INC To be discontinued 100MG Updated Report 2024-04-29 204160
PANECTYL SEARCHLIGHT PHARMA INC To be discontinued 5MG New Report 2024-04-26 226355
DELATESTRYL BAUSCH HEALTH, CANADA INC. Discontinued 200MG Updated Report 2024-04-26 221772
STRATTERA ELI LILLY CANADA INC Discontinued 18MG Updated Report 2024-04-24 171480
DULOXETINE SANIS HEALTH INC Reversed 30MG Updated Report 2024-04-23 219618
LIDOCAINE HYDROCHLORIDE INJECTION USP HIKMA CANADA LIMITED Discontinued 10MG Updated Report 2024-04-22 225805
MYLAN-VERAPAMIL MYLAN PHARMACEUTICALS ULC Discontinued 80MG Updated Report 2024-04-12 224846
TD ADSORBED SANOFI PASTEUR LIMITED To be discontinued 5LF 2LF Updated Report 2024-04-10 206909